Akero Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Akero Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2024.
  • Akero Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2024 was $5.89M, a 73.6% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $5.89M +$2.5M +73.6% Dec 31, 2024 10-K 2025-02-28
Q4 2023 $3.39M +$1.28M +60.9% Dec 31, 2023 10-K 2025-02-28
Q4 2022 $2.11M +$797K +60.7% Dec 31, 2022 10-K 2025-02-28
Q4 2021 $1.31M +$669K +104% Dec 31, 2021 10-K 2025-02-28
Q4 2020 $644K +$407K +172% Dec 31, 2020 10-K 2024-02-29
Q4 2019 $237K Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.